Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders

Summary

The main objective of this exploratory 8 week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypotheses for a larger randomized controlled clinical trial with explicit hypotheses and sufficient statistical power.

Timeline

Start

2011-11

Primary completion

2013-07

Completion

2013-07

Outcome

Outcome not reported

Stopped (Enrollment): “This study was withdrawn due to competing research interests and slow recruitment.”

Drugs

Indications